StonvexLoading…
StonvexStonvexStonvexCore line items from GEVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $160.58M | $16.91M | $17.20M | $1.18M |
Operating Income | $-20.21M | $-90.82M | $-81.83M | $-102.69M |
Net Income | $-33.84M | $-78.64M | $-66.22M | $-98.01M |
EPS (Diluted) | $-0.14 | $-0.34 | $-0.28 | $-0.44 |
Total Assets | $718.93M | $583.94M | $650.32M | $700.75M |
Total Liabilities | $247.76M | $94.45M | $92.93M | $95.27M |
Cash & Equivalents | $81.16M | $189.39M | $298.35M | $237.13M |
Free Cash Flow OCF − CapEx | $-43.51M | $-108.47M | $-108.17M | $-128.39M |
Shares Outstanding | 242.46M | 239.18M | 240.50M | 237.17M |